Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Clinical trial NCT07088731 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07088731
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-07-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.